Hong Kong · Delayed Price · Currency is HKD Kingworld Medicines Group Statistics
Total Valuation
HKG:1110 has a market cap or net worth of HKD 236.99 million. The enterprise value is 589.89 million.
| Market Cap | 236.99M |
| Enterprise Value | 589.89M |
Important Dates
The last earnings date was Thursday, August 27, 2026.
| Earnings Date | Aug 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:1110 has 592.46 million shares outstanding. The number of shares has increased by 4.02% in one year.
| Current Share Class | 592.46M |
| Shares Outstanding | 592.46M |
| Shares Change (YoY) | +4.02% |
| Shares Change (QoQ) | -2.42% |
| Owned by Insiders (%) | 70.32% |
| Owned by Institutions (%) | 5.10% |
| Float | 175.87M |
Valuation Ratios
The trailing PE ratio is 17.84.
| PE Ratio | 17.84 |
| Forward PE | n/a |
| PS Ratio | 0.26 |
| PB Ratio | 0.31 |
| P/TBV Ratio | 0.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 44.55 |
| EV / Sales | 0.65 |
| EV / EBITDA | 6.40 |
| EV / EBIT | 7.87 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.05, with a Debt / Equity ratio of 0.67.
| Current Ratio | 1.05 |
| Quick Ratio | 0.68 |
| Debt / Equity | 0.67 |
| Debt / EBITDA | 5.97 |
| Debt / FCF | n/a |
| Interest Coverage | 4.01 |
Financial Efficiency
Return on equity (ROE) is 5.18% and return on invested capital (ROIC) is 3.82%.
| Return on Equity (ROE) | 5.18% |
| Return on Assets (ROA) | 2.70% |
| Return on Invested Capital (ROIC) | 3.82% |
| Return on Capital Employed (ROCE) | 6.87% |
| Weighted Average Cost of Capital (WACC) | 4.19% |
| Revenue Per Employee | 1.28M |
| Profits Per Employee | 18,624 |
| Employee Count | 711 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 4.71 |
Taxes
In the past 12 months, HKG:1110 has paid 27.95 million in taxes.
| Income Tax | 27.95M |
| Effective Tax Rate | 40.87% |
Stock Price Statistics
The stock price has decreased by -27.27% in the last 52 weeks. The beta is 0.86, so HKG:1110's price volatility has been lower than the market average.
| Beta (5Y) | 0.86 |
| 52-Week Price Change | -27.27% |
| 50-Day Moving Average | 0.43 |
| 200-Day Moving Average | 0.47 |
| Relative Strength Index (RSI) | 40.34 |
| Average Volume (20 Days) | 2,958,800 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1110 had revenue of HKD 909.57 million and earned 13.24 million in profits. Earnings per share was 0.02.
| Revenue | 909.57M |
| Gross Profit | 277.12M |
| Operating Income | 67.35M |
| Pretax Income | 68.38M |
| Net Income | 13.24M |
| EBITDA | 84.66M |
| EBIT | 67.35M |
| Earnings Per Share (EPS) | 0.02 |
Balance Sheet
The company has 217.48 million in cash and 505.80 million in debt, with a net cash position of -288.32 million or -0.49 per share.
| Cash & Cash Equivalents | 217.48M |
| Total Debt | 505.80M |
| Net Cash | -288.32M |
| Net Cash Per Share | -0.49 |
| Equity (Book Value) | 753.29M |
| Book Value Per Share | 1.18 |
| Working Capital | 24.96M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 17.53M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 30.47%, with operating and profit margins of 7.40% and 1.46%.
| Gross Margin | 30.47% |
| Operating Margin | 7.40% |
| Pretax Margin | 7.52% |
| Profit Margin | 1.46% |
| EBITDA Margin | 9.31% |
| EBIT Margin | 7.40% |
| FCF Margin | n/a |
Dividends & Yields
HKG:1110 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.02% |
| Shareholder Yield | -4.02% |
| Earnings Yield | 5.59% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |